Lrp-1: A checkpoint for the extracellular matrix proteolysis

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Etique, Nicolas ^a   Verzeaux, Laurie ^a   Dedieu, Stéphane ^a   Emonard, Hervé ^a  

^a UFR Sciences Exactes et Naturelles   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; COLLAGENASE 3; FIBRONECTIN; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN; HEPARANASE; LAMININ; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLASMIN; PROTEIN KINASE B; PROTEOGLYCAN; THROMBOSPONDIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; LDLR RELATED PROTEIN 1A, HUMAN; LDLR-RELATED PROTEIN 1A, HUMAN; LIGAND; PROTEIN BINDING;

ANTIGEN PRESENTING CELL; ARTICLE; BINDING SITE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; EMBRYO DEVELOPMENT; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; GENE DELETION; INTERNALIZATION; MEMBRANE PERMEABILITY; MICROVASCULAR ENDOTHELIAL CELL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; HUMAN; METABOLISM; REVIEW;

ENDOCYTOSIS; EXTRACELLULAR MATRIX; HUMANS; LIGANDS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; PROTEIN BINDING; PROTEOLYSIS; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84880862717     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/152163     Document Type: Article

References (83)

1. Lu P., Weaver V. M., Werb Z., The extracellular matrix: a dynamic niche in cancer progression. Journal of Cell Biology 2012 196 4 395 406 2-s2.0-84859949610 10.1083/jcb.201102147
2. Andreasen P. A., Egelund R., Petersen H. H., The plasminogen activation system in tumor growth, invasion, and metastasis. Cellular and Molecular Life Sciences 2000 57 1 25 40 2-s2.0-0033981473 10.1007/s000180050497 (Pubitemid 30105328)
3. Murphy G., Nagase H., Progress in matrix metalloproteinase research. Molecular Aspects of Medicine 2008 29 5 290 308 2-s2.0-52949084668 10.1016/j.mam.2008.05.002
4. Borth W.,α2-Macroglobulin, a multifunctional binding protein with targeting characteristics. The FASEB Journal 1992 6 15 3345 3353 2-s2.0-0027076834 (Pubitemid 23007099)
5. Binder B. R., Christ G., Gruber F., Grubic N., Hufnagl P., Krebs M., Mihaly J., Prager G. W., Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News in Physiological Sciences 2002 17 2 56 61 2-s2.0-0036544849
6. Murphy G., Tissue inhibitors of metalloproteinases. Genome Biology 2011 12 11, article 233 2-s2.0-81255188391 10.1186/gb-2011-12-11-233
7. Murphy G., The ADAMs: signalling scissors in the tumour microenvironment. Nature Reviews Cancer 2008 8 12 929 941 2-s2.0-56749133149 10.1038/nrc2459
8. Lillis A. P., Van Duyn L. B., Murphy-Ullrich J. E., Strickland D. K., LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiological Reviews 2008 88 3 887 918 2-s2.0-50349092250 10.1152/physrev.00033.2007
9. Danø K., Andreasen P. A., Grøndahl-Hansen J., Kristensen P., Nielsen L. S., Skriver L., Plasminogen activators, tissue degradation, and cancer. Advances in Cancer Research 1985 44 139 266 2-s2.0-0021780949 10.1016/S0065-230X(08)60028-7
10. Deryugina E. I., Quigley J. P., Cell surface remodeling by plasmin: a new function for an old enzyme. Journal of Biomedicine and Biotechnology 2012 2012 21 564259 10.1155/2012/564259
11. Ellis V., Wun T.-C., Behrendt N., Ronne E., Dano K., Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. The Journal of Biological Chemistry 1990 265 17 9904 9908 2-s2.0-0025288990
12. Kanse S. M., Kost C., Wilhelm O. G., Andreasen P. A., Preissner K. T., The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Experimental Cell Research 1996 224 2 344 353 2-s2.0-0029873910 10.1006/excr.1996.0144 (Pubitemid 26140568)
13. Czekay R.-P., Aertgeerts K., Curriden S. A., Loskutoff D. J., Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. Journal of Cell Biology 2003 160 5 781 791 2-s2.0-0037416209 10.1083/jcb.200208117 (Pubitemid 36298272)
14. Bajou K., Noël A., Gerard R. D., Masson V., Brunner N., Holst-Hansen C., Skobe M., Fusenig N. E., Carmeliet P., Collen D., Foidart J. M., Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nature Medicine 1998 4 8 923 928 2-s2.0-0031902286 10.1038/nm0898-923 (Pubitemid 28364031)
15. Kessenbrock K., Plaks V., Werb Z., Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010 141 1 52 67 2-s2.0-77950931419 10.1016/j.cell.2010.03.015
16. Hua H., Li M., Luo T., Yin Y., Jiang Y., Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cellular and Molecular Life Sciences 2011 68 23 3853 3868 2-s2.0-82255186386 10.1007/s00018-011-0763-x
17. Bourboulia D., Stetler-Stevenson W. G., Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Seminars in Cancer Biology 2010 20 3 161 168 2-s2.0-77956301181 10.1016/j.semcancer.2010.05.002
18. Nagase H., Visse R., Murphy G., Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research 2006 69 3 562 573 2-s2.0-31344458952 10.1016/j.cardiores.2005.12.002 (Pubitemid 43139720)
19. Baker A. H., Edwards D. R., Murphy G., Metalloproteinase inhibitors: biological actions and therapeutic opportunities. Journal of Cell Science 2002 115 19 3719 3727 2-s2.0-0036800192 10.1242/jcs.00063 (Pubitemid 35203598)
20. Brew K., Nagase H., The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochimica et Biophysica Acta 2010 1803 1 55 71 2-s2.0-77049113770 10.1016/j.bbamcr.2010.01. 003
21. Nishida Y., Miyamori H., Thompson E. W., Takino T., Endo Y., Sato H., Activation of matrix metalloproteinase-2 (MMP-2) by membrane type 1 matrix metalloproteinase through an artificial receptor for ProMMP-2 generates active MMP-2. Cancer Research 2008 68 21 9096 9104 2-s2.0-55349094310 10.1158/0008-5472.CAN-08-2522
22. Chirco R., Liu X.-W., Jung K.-K., Kim H.-R. C., Novel functions of TIMPs in cell signaling. Cancer and Metastasis Reviews 2006 25 1 99 113 2-s2.0-33646541350 10.1007/s10555-006-7893-x (Pubitemid 43723986)
23. Stetler-Stevenson W. G., Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Science Signaling 2008 1 27, article re6 2-s2.0-48849107531 10.1126/scisignal.127re6
24. Lambert E., Bridoux L., Devy J., Dassé E., Sowa M.-L., Duca L., Hornebeck W., Martiny L., Petitfrère-Charpentier E., TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival. International Journal of Biochemistry and Cell Biology 2009 41 5 1102 1115 2-s2.0-59849109742 10.1016/j.biocel.2008.10.017
25. Bridoux L., Etique N., Lambert E., Thevenard J., Sowa M. L., Belloy N., Dauchez M., Martiny L., Charpentier E., A crucial role for Lyn in TIMP-1 erythroid cell survival signalling pathway. FEBS Letters 2013 587 10 1524 1528
26. Jung K.-K., Liu X.-W., Chirco R., Fridman R., Kim H.-R. C., Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. The EMBO Journal 2006 25 17 3934 3942 2-s2.0-33748371637 10.1038/sj.emboj.7601281 (Pubitemid 44338736)
27. Xia Y., Yeddula N., Leblanc M., Ke E., Zhang Y., Oldfield E., Shaw R. J., Verma I. M., Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model. Nature Cell Biology 2012 14 3 257 265 2-s2.0-84857785719 10.1038/ncb2428
28. Herz J., Strickland D. K., LRP: a multifunctional scavenger and signaling receptor. The Journal of Clinical Investigation 2001 108 6 779 784 2-s2.0-0034836428 10.1172/JCI200113992 (Pubitemid 32880284)
29. Strickland D. K., Ashcom J. D., Williams S., Burgess W. H., Migliorini M., Scott Argraves W., Sequence identity between theα2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. The Journal of Biological Chemistry 1990 265 29 17401 17404 2-s2.0-0025080835
30. Stebbing J., Savage P., Patterson S., Gazzard B., All for CD91 and CD91 for all. Journal of Antimicrobial Chemotherapy 2004 53 1 1 3 2-s2.0-0347917224 10.1093/jac/dkh010 (Pubitemid 38072175)
31. Herz J., Clouthier D. E., Hammer R. E., LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 1992 71 3 411 421 2-s2.0-0026439778 10.1016/0092-8674(92) 90511-A
32. Kristensen T., Moestrup S. K., Gliemann J., Bendtsen L., Sand O., Sottrup-Jensen L., Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is theα2-macroglobulin receptor. FEBS Letters 1990 276 1-2 151 155 2-s2.0-0025666455 10.1016/0014-5793(90)80530-V
33. Morton P. A., Owensby D. A., Sobel B. E., Schwartz A. L., Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1. The Journal of Biological Chemistry 1989 264 13 7228 7235 2-s2.0-0024551554 (Pubitemid 19119133)
34. Bu G., Morton P. A., Schwartz A. L., Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells: a plasminogen activator inhibitor type 1-independent t-PA receptor. The Journal of Biological Chemistry 1992 267 22 15595 15602 2-s2.0-0026625665
35. Bu G., Williams S., Strickland D. K., Schwartz A. L., Low density lipoprotein receptor-related protein/α2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proceedings of the National Academy of Sciences of the United States of America 1992 89 16 7427 7431 2-s2.0-0026756089
36. Orth K., Madison E. L., Gething M.-J., Sambrook J. F., Herz J., Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/α2-macroglobulin receptor. Proceedings of the National Academy of Sciences of the United States of America 1992 89 16 7422 7426 2-s2.0-0026668601
37. Orth K., Willnow T., Herz J., Gething M. J., Sambrook J., Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator. The Journal of Biological Chemistry 1994 269 33 21117 21122 2-s2.0-0027980974 (Pubitemid 24266483)
38. Nykjaer A., Petersen C. M., Moller B., Jensen P. H., Moestrup S. K., Holtet T. L., Etzerodt M., Thogersen H. C., Munch M., Andreasen P. A., Gliemann J., Purifiedα2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. Evidence that theα2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. The Journal of Biological Chemistry 1992 267 21 14543 14546 2-s2.0-0001353920
39. Croucher D., Saunders D. N., Ranson M., The urokinase/PAI-2 complex: a new high affinity ligand for the endocytosis receptor low density lipoprotein receptor-related protein. The Journal of Biological Chemistry 2006 281 15 10206 10213 2-s2.0-33744512466 10.1074/jbc.M513645200 (Pubitemid 43864557)
40. Kounnas M. Z., Henkin J., Argraves W. S., Strickland D. K., Low density lipoprotein receptor-related protein/α2-macroglobulin receptor mediates cellular uptake of pro-urokinase. The Journal of Biological Chemistry 1993 268 29 21862 21867 2-s2.0-0027370718 (Pubitemid 23320688)
41. Stefansson S., Muhammad S., Cheng X.-F., Battey F. D., Strickland D. K., Lawrence D. A., Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. The Journal of Biological Chemistry 1998 273 11 6358 6366 2-s2.0-0032513248 10.1074/jbc.273.11.6358 (Pubitemid 28144727)
42. Cubellis M. V., Andreasen P., Ragno P., Mayer M., Dano K., Blasi F., Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proceedings of the National Academy of Sciences of the United States of America 1989 86 13 4828 4832 2-s2.0-0024349195 (Pubitemid 19182193)
43. Cubellis M. V., Wun T.-C., Blasi F., Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. The EMBO Journal 1990 9 4 1079 1085 2-s2.0-0025273735
44. Nykjaer A., Conese M., Christensen E. I., Olson D., Cremona O., Gliemann J., Blasi F., Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. The EMBO Journal 1997 16 10 2610 2620 2-s2.0-0030926412 10.1093/emboj/16.10.2610 (Pubitemid 27226200)
45. Zhang J.-C., Sakthivel R., Kniss D., Graham C. H., Strickland D. K., McCrae K. R., The low density lipoprotein receptor-related protein/α2- macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells. The Journal of Biological Chemistry 1998 273 48 32273 32280 2-s2.0-0033610918 10.1074/jbc.273.48.32273 (Pubitemid 29177174)
46. Czekay R.-P., Kuemmel T. A., Orlando R. A., Farquhar M. G., Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Molecular Biology of the Cell 2001 12 5 1467 1479 2-s2.0-0034756167 (Pubitemid 33044425)
47. Chazaud B., Ricoux R., Christov C., Plonquet A., Gherardi R. K., Barlovatz-Meimon G., Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. American Journal of Pathology 2002 160 1 237 246 2-s2.0-0036142749 (Pubitemid 34052284)
48. Emonard H., Bellon G., de Diesbach P., Mettlen M., Hornebeck W., Courtoy P. J., Regulation of matrix metalloproteinase (MMP) activity by the low-density lipoprotein receptor-related protein (LRP). A new function for an 'old friend'. Biochimie 2005 87 3-4 369 376 2-s2.0-15244352841 10.1016/j.biochi.2004.11.013 (Pubitemid 40387616)
49. Yang Z., Strickland D. K., Bornstein P., Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. The Journal of Biological Chemistry 2001 276 11 8403 8408 2-s2.0-0035896646 10.1074/jbc.M008925200
50. Emonard H., Bellon G., Troeberg L., Berton A., Robinet A., Henriet P., Marbaix E., Kirkegaard K., Patthy L., Eeckhout Y., Nagase H., Hornebeck W., Courtoy P. J., Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2-TIMP-2 complex through a thrombospondin- independent mechanism. The Journal of Biological Chemistry 2004 279 52 54944 54951 2-s2.0-19944428578 10.1074/jbc.M406792200 (Pubitemid 40053241)
51. Barmina O. Y., Walling H. W., Fiacco G. J., Freije J. M. P., López-Otín C., Jeffrey J. J., Partridge N. C., Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. The Journal of Biological Chemistry 1999 274 42 30087 30093 2-s2.0-0033569725 10.1074/jbc.274.42.30087 (Pubitemid 29483392)
52. Hahn-Dantona E., Ruiz J. F., Bornstein P., Strickland D. K., The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. The Journal of Biological Chemistry 2001 276 18 15498 15503 2-s2.0-0035805530 10.1074/jbc.M100121200
53. Van den Steen P. E., Van Aelst I., Hvidberg V., Piccard H., Fiten P., Jacobsen C., Moestrup S. K., Fry S., Royle L., Wormald M. R., Wallis R., Rudd P. M., Dwek R. A., Opdenakker G., The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. The Journal of Biological Chemistry 2006 281 27 18626 18637 2-s2.0-33745856212 10.1074/jbc.M512308200 (Pubitemid 44035522)
54. Troeberg L., Fushimi K., Khokha R., Emonard H., Ghosh P., Nagase H., Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases. The FASEB Journal 2008 22 10 3515 3524 2-s2.0-54049085750 10.1096/fj.08-112680
55. Scilabra S. D., Troeberg L., Yamamoto K., Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1. The Journal of Biological Chemistry 2013 288 1 332 342
56. Barash U., Cohen-Kaplan V., Dowek I., Sanderson R. D., Ilan N., Vlodavsky I., Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. FEBS Journal 2010 277 19 3890 3903 2-s2.0-77956624954 10.1111/j.1742-4658.2010.07799.x
57. Vreys V., Delande N., Zhang Z., Coomans C., Roebroek A., Dürr J., David G., Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans. The Journal of Biological Chemistry 2005 280 39 33141 33148 2-s2.0-25844507098 10.1074/jbc.M503007200 (Pubitemid 41397110)
58. Yamamoto K., Troeberg L., Scilabra S. D., LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage. The FASEB Journal 2013 27 2 511 521
59. Briozzo P., Morisset M., Capony F., Rougeot C., Rochefort H., In vitro degradation of extracellular matrix with M(r) 52,000 cathepsin D secreted by breast cancer cells. Cancer Research 1988 48 13 3688 3692 2-s2.0-0023784140
60. Beaujouin M., Prébois C., Derocq D., Laurent-Matha V., Masson O., Pattingre S., Coopman P., Bettache N., Grossfield J., Hollingsworth R. E., Zhang H., Yao Z., Hyman B. T., Van Der Geer P., Smith G. K., Liaudet-Coopman E., Pro-cathepsin D interacts with the extracellular domain of the β chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth. Journal of Cell Science 2010 123 19 3336 3346 2-s2.0-77956892285 10.1242/jcs.070938
61. Derocq D., Prébois C., Beaujouin M., Laurent-Matha V., Pattingre S., Smith G. K., Liaudet-Coopman E., Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis. Oncogene 2012 31 26 3202 3212 2-s2.0-80855123988 10.1038/onc.2011.501
62. May P., Woldt E., Matz R. L., Boucher P., The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Annals of Medicine 2007 39 3 219 228 2-s2.0-34247557490 10.1080/07853890701214881 (Pubitemid 46676481)
63. Dedieu S., Langlois B., Devy J., Sid B., Henriet P., Sartelet H., Bellon G., Emonard H., Martiny L., LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities. Molecular and Cellular Biology 2008 28 9 2980 2995 2-s2.0-42349102043 10.1128/MCB.02238-07 (Pubitemid 351556530)
64. Langlois B., Perrot G., Schneider C., Henriet P., Emonard H., Martiny L., Stéphane D., LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS ONE 2010 5 7 2-s2.0-77955366419 10.1371/journal.pone.0011584 e11584
65. Hardy M. M., Feder J., Wolfe R. A., Bu G., Low density lipoprotein receptor-related protein modulates the expression of tissue-type plasminogen activator in human colon fibroblasts. The Journal of Biological Chemistry 1997 272 10 6812 6817 2-s2.0-0030889997 10.1074/jbc.272.10.6812 (Pubitemid 27118171)
66. Wang X., Lee S.-R., Arai K., Lee S.-R., Tsuji K., Rebeck G. W., Lo E. H., Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nature Medicine 2003 9 10 1313 1317 2-s2.0-0142137232 10.1038/nm926 (Pubitemid 37279856)
67. Hu K., Yang J., Tanaka S., Gonias S. L., Mars W. M., Liu Y., Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. The Journal of Biological Chemistry 2006 281 4 2120 2127 2-s2.0-33644869414 10.1074/jbc.M504988200 (Pubitemid 43845801)
68. Fayard B., Bianchi F., Dey J., Moreno E., Djaffer S., Hynes N. E., Monard D., The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Research 2009 69 14 5690 5698 2-s2.0-67651007506 10.1158/0008-5472.CAN-08-4573
69. Cáceres L. C., Bonacci G. R., Sánchez M. C., Chiabrando G. A., Activatedα2 macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF- B activation in macrophage-derived cell lines. Journal of Cellular Biochemistry 2010 111 3 607 617 2-s2.0-78650699364 10.1002/jcb.22737
70. Song H., Li Y., Lee J., Schwartz A. L., Bu G., Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Research 2009 69 3 879 886 2-s2.0-59149098234 10.1158/0008-5472.CAN-08-3379
71. Hartmann M., Herrlich A., Herrlich P., Who decides when to cleave an ectodomain? Trends in Biochemical Sciences 2013 38 3 111 120
72. Quinn K. A., Pye V. J., Dai Y.-P., Chesterman C. N., Owensby D. A., Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP). Experimental Cell Research 1999 251 2 433 441 2-s2.0-0033568616 10.1006/excr.1999.4590 (Pubitemid 29431880)
73. Quinn K. A., Grimsley P. G., Dai Y.-P., Tapner M., Chesterman C. N., Owensby D. A., Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. The Journal of Biological Chemistry 1997 272 38 23946 23951 2-s2.0-0030863621 10.1074/jbc.272.38.23946 (Pubitemid 27410977)
74. Liu Q., Zhang J., Tran H., Verbeek M. M., Reiss K., Estus S., Bu G., LRP1 shedding in human brain: roles of ADAM10 and ADAM17. Molecular Neurodegeneration 2009 4 1, article 17 2-s2.0-65349140569 10.1186/1750-1326-4-17
75. Selvais C., D'Auria L., Tyteca D., Perrot G., Lemoine P., Troeberg L., Dedieu S., Noël A., Nagase H., Henriet P., Courtoy P. J., Marbaix E., Emonard H., Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function. The FASEB Journal 2011 25 8 2770 2781 2-s2.0-80051685667 10.1096/fj.10-169508
76. Rozanov D. V., Hahn-Dantona E., Strickland D. K., Strongin A. Y., The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. The Journal of Biological Chemistry 2004 279 6 4260 4268 2-s2.0-1042301387 10.1074/jbc.M311569200 (Pubitemid 38199013)
77. Polavarapu R., Gongora M. C., Yi H., Ranganthan S., Lawrence D. A., Strickland D., Yepes M., Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 2007 109 8 3270 3278 2-s2.0-34147143557 10.1182/blood-2006-08-043125 (Pubitemid 46572512)
78. von Arnim C. A. F., Kinoshita A., Peltan I. D., Tangredi M. M., Herl L., Lee B. M., Spoelgen R., Hshieh T. T., Ranganathan S., Battey F. D., Liu C.-X., Bacskai B. J., Sever S., Irizarry M. C., Strickland D. K., Hyman B. T., The low density lipoprotein receptor-related protein (LRP) is a novel β -secretase (BACE1) substrate. The Journal of Biological Chemistry 2005 280 18 17777 17785 2-s2.0-24044497252 10.1074/jbc.M414248200 (Pubitemid 41389016)
79. An J., Zhang C., Polavarapu R., Zhang X., Zhang X., Yepes M., Tissue-type plasminogen activator and the low-density lipoprotein receptor related protein induce Akt phosphorylation in the ischemic brain. Blood 2008 112 7 2787 2794 2-s2.0-53449099141 10.1182/blood-2008-02-141630
80. Grimsley P. G., Quinn K. A., Owensby D. A., Soluble low-density lipoprotein receptor-related protein. Trends in Cardiovascular Medicine 1998 8 8 363 368 2-s2.0-0031673996 10.1016/S1050-1738(98)00029-2 (Pubitemid 28565201)
81. Wygrecka M., Wilhelm J., Jablonska E., Zakrzewicz D., Preissner K. T., Seeger W., Guenther A., Markart P., Shedding of low-density lipoprotein receptor-related protein-1 in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2011 184 4 438 448 2-s2.0-80051824506 10.1164/rccm.201009-1422OC
82. Selvais C., Gaide Chevronnay H. P., Lemoine P., Dedieu S., Henriet P., Courtoy P. J., Marbaix E., Emonard H., Metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 ectodomain decreases endocytic clearance of endometrial matrix metalloproteinase-2 and -9 at menstruation. Endocrinology 2009 150 8 3792 3799 2-s2.0-67651148199 10.1210/en.2009-0015
83. Perrot G., Langlois B., Devy J., LRP-1:CD44, identification of a new cell surface complex regulating tumor cell adhesion. Molecular and Cellular Biology 2012 32 16 3293 3307